Get started
Author

Carolin Kurz

Observed names: C Kurz, C. Kurz, Carolin Isabella Dr. Kurz, Carolin I. Kurz, Carolin Isabella Kurz, Kurz, Carolin, Kurz, Carolin Isabella
Institutions: German Center for Neurodegenerative Diseases, TUM Klinikum, LMU Klinikum, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technical University of Munich, Ludwig-Maximilians-Universität München
Observed institutions: Centers for Disease Control and Prevention, German Center for Neurodegenerative Diseases, TUM Klinikum, LMU Klinikum, University Hospital, University Medical Center Hamburg-Eppendorf, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Division of Parasitic Diseases and Malaria, Technical University of Munich, Ludwig-Maximilians-Universität München
ORCID: 0000-0003-4299-6240
Observed ORCID: 0000-0003-4299-6240
OpenAlex ID: A5066599136
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
2017 · Günter U. Höglinger, Gesine Respondek, et al. · Movement Disorders · 2,360
Distribution patterns of tau pathology in progressive supranuclear palsy
2020 · Gabor G. Kovacs, Milica Jecmenica Lukic, et al. · Acta Neuropathologica · 478
PDF
The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases
2014 · Gesine Respondek, Maria Stamelou, et al. · Movement Disorders · 385
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
2017 · Jennifer L. Whitwell, Günter U. Höglinger, et al. · Movement Disorders · 260
PDF
Dysfunction of the blood–brain barrier in Alzheimer's disease: Evidence from human studies
2021 · Carolin Kurz, Lauren Walker, et al. · Neuropathology and Applied Neurobiology · 183
PDF
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
2017 · Gesine Respondek, Carolin Kurz, et al. · Movement Disorders · 169
PDF
Tau deposition patterns are associated with functional connectivity in primary tauopathies
2022 · Nicolai Franzmeier, Matthias Brendel, et al. · Nature Communications · 114
PDF
Copathology in Progressive Supranuclear Palsy: Does It Matter?
2020 · Milica Jecmenica Lukic, Carolin Kurz, et al. · Movement Disorders · 91
PDF
Microglial Activation and Connectivity in Alzheimer Disease and Aging
2022 · Boris‐Stephan Rauchmann, Matthias Brendel, et al. · Annals of Neurology · 60
PDF
Perivascular space and white matter hyperintensities in Alzheimer’s disease: associations with disease progression and cognitive function
2025 · Philine Marie Schirge, Robert Perneczky, et al. · Alzheimer s Research & Therapy · 49
What is frontotemporal dementia?
2014 · Alexander Kurz, Carolin Kurz, et al. · Maturitas · 49
Impact of pre‐analytical sample handling factors on plasma biomarkers of Alzheimer's disease
2023 · Carolin Kurz, Laura Stöckl, et al. · Journal of Neurochemistry · 47
PDF
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
2023 · Anika Finze, Gloria Biechele, et al. · Molecular Psychiatry · 39
PDF
An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability
2016 · Carolin Kurz, Georg Ebersbach, et al. · Acta Neuropathologica Communications · 34
PDF
Additive value of [18F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
2022 · Sabrina Katzdobler, Alexander Nitschmann, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 33
PDF
Long‐Duration Progressive Supranuclear Palsy: Clinical Course and Pathological Underpinnings
2022 · Milica Jecmenica Lukic, Gesine Respondek, et al. · Annals of Neurology · 33
PDF
Early Neurodegeneration in the Brain of a Child Without Functional PKR-like Endoplasmic Reticulum Kinase
2015 · Julius Bruch, Carolin Kurz, et al. · Journal of Neuropathology & Experimental Neurology · 29
Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease
2024 · Gloria Biechele, Boris-Stephan Rauchmann, et al. · Journal of Neuroinflammation · 27
PDF
Combining cerebrospinal fluid and PI‐2620 tau‐PET for biomarker‐based stratification of Alzheimer's disease and 4R‐tauopathies
2024 · Roxane Dilcher, Stephan Wall, et al. · Alzheimer s & Dementia · 23
PDF
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer’s disease
2025 · Carolin Meyer, Theresa Niedermeier, et al. · Nature Communications · 21
PDF
Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer's disease
2022 · Ersin Ersoezlue, Boris-Stephan Rauchmann, et al. · Neurobiology of Aging · 20
Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study
2023 · Laura Perna, Hannah Stocker, et al. · Alzheimer s Research & Therapy · 17
PDF
Biobanking in everyday clinical practice in psychiatry—The Munich Mental Health Biobank
2022 · JL Kalman, G Burkhardt, et al. · Frontiers in Psychiatry · 16
PDF
Plasma biomarkers of amyloid, tau & neuroinflammation in Alzheimer’s disease and corticobasal syndrome
2025 · Carolin Kurz, Laura Carli, et al. · European Archives of Psychiatry and Clinical Neuroscience · 13
PDF
Aβ status assessment in a hypothetical scenario prior to treatment with disease‐modifying therapies: Evidence from 10‐year real‐world experience at university memory clinics
2024 · Matthias Brendel, Tandis Parvizi, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 8
PDF
Works count: 74
Citation count: 4,623
H-index: 20
I10-index: 24
Year
Topic
Type